Related Experiment Video
Updated: Jun 26, 2026

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
Chloride channels as drug targets
Alan S Verkman1, Luis J V Galietta
1Departments of Medicine and Physiology, University of California, San Francisco, California 94143-0521, USA. Alan.Verkman@ucsf.edu
Chloride channels are crucial for many bodily functions and linked to diseases like cystic fibrosis. Exploring chloride channel modulators offers significant drug discovery opportunities for various conditions.
Area of Science:
- Biochemistry
- Pharmacology
- Physiology
Background:
- Chloride channels are under-explored drug targets despite their critical physiological roles.
- Their involvement spans epithelial transport, cell volume, neural activity, and organelle acidification.
- Dysfunction of chloride channels is implicated in numerous human diseases.
Purpose of the Study:
- To highlight the therapeutic potential of chloride channels as drug targets.
- To review the current landscape of chloride channel research and drug discovery.
- To emphasize the broad opportunities for developing novel chloride channel modulators.
Main Methods:
- Literature review of chloride channel physiology and pathology.
- Analysis of current drug discovery efforts targeting chloride channels.
- Discussion of existing and potential therapeutic applications.
Main Results:
- Chloride channels are implicated in diseases such as cystic fibrosis, macular degeneration, and hypertension.
- Modulators of GABA(A) receptor chloride channels are in clinical use.
- Several small-molecule chloride channel modulators are in preclinical and clinical development.
Conclusions:
- Chloride channels represent a promising, yet underexplored, avenue for drug discovery.
- Targeting chloride channels offers potential treatments for a wide range of disorders.
- Further research into chloride channel modulators is warranted to address unmet medical needs.
More Related Videos
Related Concept Videos
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.

